Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer
As gene transfer with adeno-associated virus (AAV) vectors is starting to enter clinical practice, this review examines the impact of vector capsid choice in liver-directed gene transfer for hemophilia. Given that there are multiple clinical trials completed and ongoing in this field, it is importan...
Main Authors: | Steven Pipe, Frank W.G. Leebeek, Valerie Ferreira, Eileen K. Sawyer, John Pasi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050119300956 |
Similar Items
-
Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
by: Hildegard Büning, et al.
Published: (2019-03-01) -
Tyrosine Mutation in AAV9 Capsid Improves Gene Transfer to the Mouse Lung
by: Sabrina V. Martini, et al.
Published: (2016-07-01) -
Microglia-specific targeting by novel capsid-modified AAV6 vectors
by: Awilda M Rosario, et al.
Published: (2016-01-01) -
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
by: Christine N Kay, et al.
Published: (2013-01-01) -
AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
by: Daniel J Hui, et al.
Published: (2015-01-01)